Curaderm BCC is a topical treatment with keratolytic action in the treatment and healing of localized basal cell carcinoma of the skin.
Decades of scientific research about the anti-tumoral properties of natural glycoalkaloids actives derived from the Solanaceae plant group have led to the formulation of Curaderm BCC. A treatment that incorporates the keratolytic action of salicylic acid, lactic acid and urea to remedy celular proliferation activity also by the cytoprotective action of the glycoalkaloids. Moreover, It allows the entry of other therapeutic agents, including molecules with pharmacological actions.
Aqua, Salicylic acid paraffinum liquidum, petrolatum, lactic acid, cetearyl alcohol, ceteareth-20, urea, propylene glycol, solasodine rhamnoside, xantham gum, p-chlorocresol.
Download the Package leaflet and Instructions for use